MarketCap
Facebook
X
TelegramAnnual report 2025
added 03-13-2026
Harvard Bioscience Cash Conversion Cycle 2011-2026 | HBIO
Annual Cash Conversion Cycle Harvard Bioscience
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 243 | 234 | 208 | 210 | 200 | 198 | 183 | 187 | 180 | 159 | 155 | 158 | 132 | 144 | 141 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 243 | 132 | 182 |
Quarterly Cash Conversion Cycle Harvard Bioscience
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 234 | 239 | 233 | - | 251 | 228 | 233 | - | 233 | 214 | 213 | - | - | 113 | 230 | - | 183 | 173 | 187 | - | 208 | 227 | 213 | 172 | 192 | 176 | 199 | 165 | 195 | 162 | 161 | 163 | 188 | 179 | 214 | 142 | 152 | 142 | 145 | 137 | 151 | 132 | 148 | 127 | 151 | 143 | 130 | 110 | 131 | 128 | 129 | 127 | 135 | 126 | 128 | 124 | 135 | 67.3 | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 251 | 67.3 | 170 |
Cash Conversion Cycle of other stocks in the Medical instruments industry
| Issuer | Cash Conversion Cycle | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Atrion Corporation
ATRI
|
253 K | - | - | $ 810 M |  USA |
 |
Luminex Corporation
LMNX
|
18.9 | - | - | $ 1.75 B | USA |
 |
Akers Biosciences, Inc.
AKER
|
95.3 | - | -9.52 % | $ 20.6 M | USA |
 |
iRhythm Technologies
IRTC
|
59.8 | $ 126.93 | 3.74 % | $ 4.06 B | USA |
 |
Alcon
ALC
|
134 | $ 76.13 | 0.46 % | $ 40.4 B |  Schweiz |
 |
Ekso Bionics Holdings
EKSO
|
404 | $ 10.93 | -0.55 % | $ 26.5 M | USA |
 |
The Cooper Companies
COO
|
210 | $ 64.3 | -0.19 % | $ 12.8 B | USA |
 |
Antares Pharma, Inc.
ATRS
|
204 | - | - | $ 955 M | USA |
 |
Repro Med Systems
KRMD
|
83.1 | $ 4.03 | 1.77 % | $ 186 M | USA |
 |
Cantel Medical Corp.
CMD
|
400 | - | -1.18 % | $ 3.4 B | USA |
 |
Hill-Rom Holdings, Inc.
HRC
|
11.9 | - | -0.05 % | $ 10.3 B | USA |
 |
Microbot Medical
MBOT
|
-52.9 | $ 2.17 | -1.36 % | $ 99.4 M |  Israel |
 |
Milestone Scientific
MLSS
|
533 | $ 0.32 | 1.15 % | $ 26.3 M | USA |
 |
Varian Medical Systems, Inc.
VAR
|
194 | - | -0.02 % | $ 16.3 B | USA |
 |
Haemonetics Corporation
HAE
|
217 | $ 60.81 | 1.38 % | $ 3.06 B | USA |
 |
electroCore
ECOR
|
-39.3 | $ 6.07 | -1.7 % | $ 51.5 K | USA |
 |
ICU Medical
ICUI
|
146 | $ 122.32 | -2.0 % | $ 3.01 B | USA |
 |
Envista Holdings Corporation
NVST
|
77.3 | $ 26.79 | - | $ 4.5 B | USA |
 |
Isoray
ISR
|
173 | - | 0.03 % | $ 108 M | USA |
 |
Intuitive Surgical
ISRG
|
203 | $ 471.29 | -2.27 % | $ 168 B | USA |
 |
Glaukos Corporation
GKOS
|
170 | $ 121.88 | 0.18 % | $ 5.9 B | USA |
 |
STERIS plc
STE
|
112 | $ 221.92 | 0.08 % | $ 21.9 B | USA |
 |
Teleflex Incorporated
TFX
|
285 | $ 136.38 | -0.13 % | $ 6.09 B | USA |
 |
Masimo Corporation
MASI
|
83.7 | $ 178.6 | -0.02 % | $ 9.52 B | USA |
 |
InfuSystem Holdings
INFU
|
24.9 | $ 10.6 | 2.71 % | $ 219 M | USA |
 |
Merit Medical Systems
MMSI
|
167 | $ 67.27 | -1.91 % | $ 3.98 B | USA |
 |
Utah Medical Products
UTMD
|
321 | $ 67.07 | -0.15 % | $ 217 M | USA |
 |
West Pharmaceutical Services
WST
|
97.3 | $ 301.01 | -1.6 % | $ 21.8 B | USA |
 |
Pulse Biosciences
PLSE
|
-1.51 K | $ 22.39 | -2.74 % | $ 1.51 B | USA |
 |
DENTSPLY SIRONA
XRAY
|
66 | $ 11.9 | -0.13 % | $ 2.37 B | USA |
 |
Retractable Technologies
RVP
|
203 | $ 0.63 | -1.72 % | $ 18.9 M | USA |
 |
Pro-Dex
PDEX
|
193 | $ 51.94 | -0.32 % | $ 171 M | USA |
 |
LeMaitre Vascular
LMAT
|
29 | $ 115.31 | 1.64 % | $ 2.61 B | USA |
 |
Predictive Oncology
POAI
|
-7.15 K | - | - | $ 31.1 M | USA |
 |
STAAR Surgical Company
STAA
|
26 | $ 26.2 | 2.06 % | $ 1.3 B | USA |
 |
BioLife Solutions
BLFS
|
37.9 | $ 21.31 | -0.33 % | $ 982 M | USA |
 |
Stereotaxis
STXS
|
143 | $ 1.94 | 0.26 % | $ 176 M | USA |
 |
Baxter International
BAX
|
106 | $ 18.46 | 1.68 % | $ 9.47 B | USA |
 |
ResMed
RMD
|
167 | $ 222.96 | 1.47 % | $ 32.6 B | USA |
 |
AtriCure
ATRC
|
185 | $ 29.06 | -0.75 % | $ 1.39 B | USA |
 |
NeuroMetrix
NURO
|
357 | - | 5.05 % | $ 9.02 M | USA |
 |
AngioDynamics
ANGO
|
124 | $ 11.01 | -0.81 % | $ 450 M | USA |
 |
Becton, Dickinson and Company
BDX
|
110 | $ 150.72 | -0.92 % | $ 43.4 B | USA |
 |
Nephros
NEPH
|
161 | $ 2.99 | 4.3 % | $ 31.1 M | USA |
 |
OraSure Technologies
OSUR
|
211 | $ 2.97 | -1.17 % | $ 218 M | USA |
 |
Repligen Corporation
RGEN
|
272 | $ 118.39 | 0.67 % | $ 6.6 M | USA |